Astria Therapeutics, Inc. (ATXS)

Astria Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	59.82	175.53	20.53	86.51	24.93
Short-Term Investments	268.31	71	205.91	39	20
Cash & Short-Term Investments	328.13	246.53	226.44	125.51	44.93
Cash Growth	33.10%	8.87%	80.42%	179.34%	23.96%
Prepaid Expenses	6.51	4.41	1.25	1.45	1.4
Restricted Cash	-	-	-	0.12	-
Total Current Assets	334.64	250.94	227.69	127.08	46.33
Property, Plant & Equipment	5.11	0.36	0.95	0.39	0.97
Other Long-Term Assets	2.61	3.36	2	0.05	0.17
Total Assets	342.36	254.67	230.63	127.51	47.46
Accounts Payable	4.32	1.51	0.79	1.56	1.54
Accrued Expenses	13.43	9.71	7.69	3.28	4.2
Current Portion of Leases	1.38	0.33	0.58	0.37	0.65
Total Current Liabilities	19.13	11.55	9.06	5.2	6.39
Long-Term Leases	3.97	-	0.36	-	0.4
Total Liabilities	23.1	11.55	9.42	5.2	6.79
Common Stock	0.06	0.04	0.03	0.01	0
Additional Paid-In Capital	898.51	728.29	632.51	481.71	301.56
Retained Earnings	-674.79	-580.53	-507.64	-455.81	-260.9
Comprehensive Income & Other	0.16	-	-0.08	-	-
Total Common Equity	223.94	147.79	124.82	25.91	40.67
Shareholders' Equity	319.26	243.12	221.22	122.31	40.67
Total Liabilities & Equity	342.36	254.67	230.63	127.51	47.46
Total Debt	5.35	0.33	0.94	0.37	1.05
Net Cash (Debt)	322.78	246.2	225.5	125.14	43.88
Net Cash Growth	31.10%	9.18%	80.19%	185.17%	29.10%
Net Cash Per Share	5.75	8.17	15.42	14.02	14.35
Filing Date Shares Outstanding	56.43	54.9	27.99	13.02	3.9
Total Common Shares Outstanding	56.43	41.03	27.5	13.02	3.35
Working Capital	315.51	239.39	218.63	121.87	39.94
Book Value Per Share	3.97	3.60	4.54	1.99	12.15
Tangible Book Value	223.94	147.79	124.82	25.91	40.67
Tangible Book Value Per Share	3.97	3.60	4.54	1.99	12.15

Updated Mar 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q